Strata Skin Sciences: Q3 Earnings Insights

Shares of Strata Skin Sciences SSKN remained unaffected after the company reported Q3 results.

Quarterly Results

Earnings per share fell 33.33% year over year to ($0.04), which were in line with the estimate of ($0.04).

Revenue of $5,613,000 decreased by 24.96% year over year, which beat the estimate of $4,900,000.

Outlook

Strata Skin Sciences hasn't issued any earnings guidance for the time being.

Strata Skin Sciences hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Nov 10, 2020

Time: 08:30 AM

ET Webcast URL: http://public.viavid.com/player/index.php?id=142365

Recent Stock Performance

52-week high: $2.73

Company's 52-week low was at $0.75

Price action over last quarter: down 22.22%

Company Description

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. The company's operating segment include Dermatology Recurring Procedures and Dermatology Procedures Equipment. It generates maximum revenue from the Dermatology Recurring Procedures segment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.